ANI PHARMACEUTICALS INC — Director's Dealing 2026

Mar 2, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2026-02-26

Reporting Person: Davis Krista (SVP, CHIEF HR OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-26	Common Stock	A	10810	$77.15	Acquired	60073	Direct
2026-02-28	Common Stock	F	1555	$73.90	Disposed	58518	Direct

Footnotes

F1: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,040 shares of restricted stock, the grant of which was previously reported.